Average Co-Inventor Count = 8.65
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (12 from 169 patents)
12 patents:
1. 11590139 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
2. 10940152 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
3. 10646493 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
4. 10576085 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
5. 10004735 - Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
6. 9795607 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
7. 9737535 - Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
8. 9737541 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
9. 9512124 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
10. 9428509 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
11. 9375443 - Method for treating advanced non-small cell lung cancer (NSCLC) by administering a combination of a TOR kinase inhibitor and azacitidine or erlotinib
12. 9346812 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith